⌘K

Login Start Free

Home/Filings/4/0000905148-25-004129

4//SEC Filing

Gamelin Erick 4

Accession 0000905148-25-004129

CIK 0001781174other

View on SEC.gov Company Profile

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 4:30 PM ET

Size

4.4 KB

Accession

0000905148-25-004129

Insider Transaction Report

Form 4

Period: 2025-11-14

Acrivon Therapeutics, Inc.ACRV

Chief Development Officer

Transactions

Tax Payment
Common Stock
2025-11-14$2.24/sh−403$903→ 15,283 total

Footnotes (1)

[F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Documents

1 file

4
form4.xmlPrimary

Issuer

Acrivon Therapeutics, Inc.

CIK 0001781174

Entity typeother

Related Parties

1

filerCIK 0001950551

Filing Metadata

Form type: 4
Filed: Nov 17, 7:00 PM ET
Accepted: Nov 18, 4:30 PM ET
Size: 4.4 KB

View on SEC.gov